Award
National Cancer Institute 5R01CA299257-02
Novel endogenous and engineered activators of STING: from mechanisms to cancer therapy
Recipient
UT Southwestern Medical Center
Award Amount
$642,739.00
Ceiling
$642,739.00
Awarded
May 07, 2026
Identifier
5R01CA299257-02
NIH awarded a research grant to UT Southwestern Medical Center for studying STING activators in cancer therapy, focusing on immune signaling and nanoparticle delivery.
Description
This is a research grant opportunity from NIH for a project on STING activators for cancer therapy. The project involves cryo-EM, molecular mechanisms, and nanoparticle delivery systems. The award is multiyear, with a focus on immune signaling and cancer immunotherapy.